Invitae Corporation

Invitae Corporation

Invitae Corporation began as an independent genetic testing firm focused on making DNA analysis part of routine healthcare. While its founding date is not specified in available sources, the company developed a broad test catalog covering areas such as hereditary cancer, carrier screening, and pediatrics. The wealth behind Invitae is not disclosed, as it was a publicly traded company prior to acquisition. The firm's strategy centers on providing genetic testing services directly to clinicians and patients, with a test menu of over 6,500 offerings (per the firm's website). Invitae covers most health plans and offers genetic counseling at no additional cost to US and Canadian patients. Its geographic footprint includes the United States and Canada. The company’s integration into Labcorp expands access through thousands of patient service centers nationwide. Invitae states it has been chosen by 5 million patients and their providers (per the firm's website). The firm's team structure is not specified in public materials, and no additional offices beyond San Francisco are listed. A notable recent operational event is the completion of Invitae’s acquisition by Labcorp, finalized in 2023, which folded the company into Labcorp's genetics division. What distinguishes Invitae structurally is its absorption into Labcorp, a global life sciences leader. Rather than operating as a standalone entity, Invitae now functions as part of a larger diagnostics and testing network, potentially changing how it sources capital and develops new tests.